Bone Biologics Earnings Estimates, EPS & Revenue | NASDAQ:BBLG

Comments

Bone Biologics Corp Earnings Estimates

BBLGNASDAQ

Trade with Public

$1.18

0.021.72%

At close: Mar 20, 5:00 PM EST

$1.14

-0.02-1.72%

Pre-Market: 5:19 AM EST

Overview NewsEarningsAnalyst Ratings Insider Trades Short Interest Stock Report

Bone Biologics Earnings Estimates, EPS & Revenue | NASDAQ:BBLG

Bone Biologics (BBLG) is scheduled to report Q1 earnings on May 11, 2026. Analysts estimate EPS of $-0.54 and quarterly revenue of N/A.

In the most recent quarter (Q4), Bone Biologics reported EPS of $-0.14, beating estimates of $-0.54 by 0.74%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Bone Biologics has beaten EPS estimates in 2 consecutive quarters.

Over the last 4 quarters, Bone Biologics has averaged an EPS surprise of 0.77% and a revenue surprise of 0.00%.

Earnings Date

May 11

EPS Estimate

$-0.540

Quarterly Revenue Estimate

–

Annual Revenue
(as of Dec 31)

–

Bone Biologics Earnings History

Analyze the earnings history of Bone Biologics using advanced sorting and filters.

Loading calendar...

Bone Biologics (BBLG) Earnings Per Share

The chart below shows Bone Biologics's reported EPS compared to analyst estimates over recent quarters.

Bone Biologics (BBLG) Revenue

The chart below shows Bone Biologics's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Bone Biologics (NASDAQ:BBLG) reporting earnings?

Bone Biologics (BBLG) is scheduled to report earnings on May 11, 2026. The last reported earnings were for reported on March 2, 2026 for Q4.

What were the latest earnings per share (EPS) for Bone Biologics (NASDAQ:BBLG)?

The Actual EPS was $-0.14, which beat the estimate of $-0.54.

What were Bone Biologics’s (NASDAQ:BBLG) revenues?

The Actual Revenue was $0.00, which hit the estimate of $0.00.

People Also Watch

ERNAW

Geovax Labs Inc

NASDAQ:GOVX

$1.50

AquaBounty Technologies Inc

NASDAQ:AQB

$0.94

0.70%

Biodexa Pharmaceuticals PLC

NASDAQ:BDRX

$0.65

-5.07%

Ensysce Biosciences Inc

NASDAQ:ENSC

$0.58

-1.02%

Psyence Biomedical Ltd

Galmed Pharmaceuticals Ltd

NASDAQ:GLMD

$0.57

-0.96%

Bone Biologics Earnings Estimates, EPS & Revenue | NASDAQ:BBLG

Bone Biologics (BBLG) is scheduled to report Q1 earnings on May 11, 2026. Analysts estimate EPS of $-0.54 and quarterly revenue of N/A.

In the most recent quarter (Q4), Bone Biologics reported EPS of $-0.14, beating estimates of $-0.54 by 0.74%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Bone Biologics has beaten EPS estimates in 2 consecutive quarters.

Over the last 4 quarters, Bone Biologics has averaged an EPS surprise of 0.77% and a revenue surprise of 0.00%.

Earnings Date

May 11

EPS Estimate

$-0.540

Quarterly Revenue Estimate

–

Annual Revenue
(as of Dec 31)

–